At ASH 2023, Ola Landgren, MD, Professor of Medicine and Chief Division of Myeloma at…

Under the lights of ASH 2023, the microphone poised to capture insights, Dr. Lorenzo Falchi,…

Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…

In the groundbreaking study conducted by Bruce Feinberg,DO, Chief Medical Officer at Cardinal Health, the…

At ASH 2023, Katherine Broome, MD, a medical doctor and medical oncologist at the Georgetown…

By. Robert Rifkin, MDDate: 12/13/2023 Robert Rifkin, MD, a medical oncologist and hematologist at SCRI…

Allen Wilbanks stands at the forefront of SABCS 2023, the setting for a conversation with…

Amidst the atmosphere of SABCS 2023, and at the center was Yara Abdou, MD, a…

Allen Wilbanks finds himself at SABCS 2023, where he engages in a discussion with Dr.…

In this ASH 2023 interview, Dr. Jos Melenhorst discusses a collaborative study on single-cell multi-omics…